We study the performance of shape-constrained methods for evaluating immune response profiles from early-phase vaccine trials. The motivating problem for this work involves quantifying and comparing the IgG binding immune responses to the first and second variable loops (V1V2 region) arising in HVTN 097 and HVTN 100 HIV vaccine trials. We consider unimodal and log-concave shape-constrained methods to compare the immune profiles of the two vaccines, which is reasonable because the data support that the underlying densities of the immune responses could have these shapes. To this end, we develop novel shape-constrained tests of stochastic dominance and shape-constrained plug-in estimators of the Hellinger distance between two densities. Our t...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, February ...
Evaluation of immunogenicity is a key step in the clinical development of novel vaccines. T-cell res...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...
Thesis (Ph.D.)--University of Washington, 2019This thesis consists of three projects, the common thr...
Thesis (Ph.D.)--University of Washington, 2023In vaccine research, it is important to identify bioma...
The efficacy of an HIV vaccine to prevent infection is likely to depend on the genetic variation of ...
Assessing immune responses to study vaccines as surrogates of protection plays a central role in vac...
Thesis (Ph.D.)--University of Washington, 2012The extensive diversity of the human immunodeficiency ...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2018.Cataloged from PDF versi...
SUMMARY. In many experiments researchers would like to compare between treatments an outcome that on...
This article introduces methods for use in vaccine clinical trials to help determine whether the imm...
International audienceEvaluation of immunogenicity is a key step in the clinical development of nove...
Evaluation of HIV vaccine candidates in non-human primates (NHPs) is a critical step toward developi...
BackgroundHIV vaccine trials routinely measure multiple vaccine-elicited immune responses to compare...
Vaccines with limited ability to prevent HIV infection may positively impact the HIV/AIDS pandemic b...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, February ...
Evaluation of immunogenicity is a key step in the clinical development of novel vaccines. T-cell res...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...
Thesis (Ph.D.)--University of Washington, 2019This thesis consists of three projects, the common thr...
Thesis (Ph.D.)--University of Washington, 2023In vaccine research, it is important to identify bioma...
The efficacy of an HIV vaccine to prevent infection is likely to depend on the genetic variation of ...
Assessing immune responses to study vaccines as surrogates of protection plays a central role in vac...
Thesis (Ph.D.)--University of Washington, 2012The extensive diversity of the human immunodeficiency ...
Thesis: Ph. D., Harvard-MIT Program in Health Sciences and Technology, 2018.Cataloged from PDF versi...
SUMMARY. In many experiments researchers would like to compare between treatments an outcome that on...
This article introduces methods for use in vaccine clinical trials to help determine whether the imm...
International audienceEvaluation of immunogenicity is a key step in the clinical development of nove...
Evaluation of HIV vaccine candidates in non-human primates (NHPs) is a critical step toward developi...
BackgroundHIV vaccine trials routinely measure multiple vaccine-elicited immune responses to compare...
Vaccines with limited ability to prevent HIV infection may positively impact the HIV/AIDS pandemic b...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Chemical Engineering, February ...
Evaluation of immunogenicity is a key step in the clinical development of novel vaccines. T-cell res...
HIV is a highly mutable virus for which all attempts to develop a vaccine have been unsuccessful. Ne...